Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Clinical Trial Perspective: Optimizing Crossover From Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome (CAPITAL OPTICROSS)

Citation:

US Cardiology Review 2017;11(2):59–61.

The Impact of an Atrial Septal Defect on Hemodynamics in Patients With Heart Failure

Citation:

US Cardiology Review 2017;11(2):72–4.

New Drugs for the Treatment of Heart Failure

Citation:

US Cardiology Review 2017;11(2):62–6.

Update on the Management of Patent Foramen Ovale in 2017: Indication for Closure and Literature Review

Citation:

US Cardiology Review 2017;11(2):75–9.